share_log

Needham Reiterates Buy on Autolus Therapeutics, Maintains $9 Price Target

Needham Reiterates Buy on Autolus Therapeutics, Maintains $9 Price Target

Needham重申买入Autolus Therapeutics,维持9美元的目标股价
Moomoo 24/7 ·  04/12 06:01

Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $9 price target.

Needham分析师吉尔·布鲁姆重申Autolus Therapeutics(纳斯达克股票代码:AUTL)的买入并维持9美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发